<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 195 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page194.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=195">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 195 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 195</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=195"><img src="../thumb/195.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Respiratory System - 10.2.4                                                    2020-04 / 161
                          +
       of hypokalaem.on card.rhythm., monit. ser. K  lev., alert dr.immed.  Side effects: Rash, trem., headache, palpitat., musc. cramps, hy-  Warnings and special precautions: Not for relief of ac.sympts.,
       in case of ac./rapid. worsen. dyspn., use only on an as-need.basis   persens.reacts.incl.oed.& angioed., hypokalaem., card.arrhythm.,   no abrupt withdr., discont.in case of paradoxic.bronchosp., pt.to con-
       in bronch. asthma/on demand treatm.poss.pref.in mild COPD, cons.  oropharyng. irrit., arthralg., mouth & throat candidias., hoarsen.,   tin. treatm. but seek med.advice if asthma sympts.remain uncontroll./
       concom.anti-inflamm.ther.in bronch. asthma & ster.respons. COPD,   adren.suppress., growth retardat. in childr.& adolesc., decr.bone min.   worsen aft.init., CV dis./heart rhythm abnormal./hyperthyroid./un-
       reg.re-eval. treatm.of long-term pts./where dos.no long.adeq., con-  density, cataract, glauc., paradoxic.bronchosp.  correct.hypokalaem., incr. hypokalaem.risk with high dos./concom.
       com. other sympathomimet. bronchodilat.not to be used, benef.vs.risk   Warnings and special precautions: Not for relief of ac.sympts.,   meds. caus.hypokalaem.& hypox./in pres.of hypox. & acidos., do
       esp.if dos.high.than recomm. used: in insuffic.contr.diab. mellit./re-  progress./sudd.deteriorat.of asthma control, poss.adrenocortic.sup-  not exceed max.dos., avoid both non-select.& select. ß-block.un-
       cent MI/sev. CV disords./hyperthyroid./phaeochromocyt., pts. with   press.with corticoster.ther., no abrupt withdr.as adren. insuffic. poss.  less there are compell. reasons, pts.with diabet.mellit.hist., system.
       underly.heart dis.to alert dr.in case of chest pain/worsen.heart dis.  precipit., act./quiesc.pulm.TB, thyrotoxicos., monit.childr.height.  corticoster.effs.may occ.at high dos., prolong.ther., pulm. TB, chron./
       sympt./dyspn., not to be used in pts.predisp.to narr.-ang.glauc./urin.   if treatm. prolong., transf.from other oral/inhal.steroids, medic. or   untreat.infects., poss.developm. of pneum. in pts. with COPD as clin.
       outflow tract obstruct./hypertens., do not allow aerosol to enter eyes,   surg.emerg./elect.proced./stress, rarely poss.unmask.of underly.eo-  feats.overlap with sympts. of COPD exacerbats., re-eval.treatm. if
       immed.treatm.with miot. drops & spec.advice if ocul.compl.devel.,   sinophil.condits., treat. concurr.infects., discont.in case of paradoxic.   pneum. occ., incr.pneum.risk in asthma pts.on high.formulat., hepat.
       GIT motil. disturbs.in cystic fibros., safety in elderly esp.card. pts. not   bronchosp., lact.intol., glycaem.control of diabet., safety in pregn.&   impairm., cont. lactose/fruct
       est., fenoterol hydrobromide excret.into breast milk.  lactat.not est., corticoster. teratogen. in anim., no data avail.in childr.  Drug interactions: ß-adrenerg.blocks.may cause bronchosp. & may
       Drug interactions: Other concom.ß-adrenerg./ anticholinerg./   und. 4 yrs.for accuhal.  weak./antagon.eff.of ß 2-adrenerg. agonists., system.expos.poss.incr.
       xanthine derivat.may potent.eff., other concom.beta-mimets./syst.  Interactions: Poss.interact.with substrates /inhibit.of CYP 3A4, avoid
       avail. anticholinerg. /xanthine derivats.poss.incr.S/E, poss. ser.re-  both non-select.& select. ß-block.unless there are compell.reasons.  with strong CYP3A4 inhibits.
       duc.therap.eff.with ß-blockers, enhanc. beta-adrenerg.agon.act.  See also MDR page 365-367.  See also MDR page 370.
       with TCA’s & MAOI, incr. suscept.to CV effs.with concom.halogen.   SEREFLO, Cipla Medpro, [PWR]
       anaesthet./ digox.            INNUVAIR, AI Pharm Ltd       Salmeterol 25 µg, fluticasone propionate 50 µg, (125 µg & 250 µg)/
       DURO-TUSS, iNova              Beclomethasone dipropionate100 µg, formoterol fumarate 6  µg/  actuat.
                                     met dos.
       Salbutamol sulph.2,41 mg, bromhexine HCl 4 mg/5 ml  Indications: Reg.asthma treatm.where a combinat. corticoster.&   Indications: Reg.prophylact.treatm.of atop. asthma when stabilis.
       Indications: Cough assoc with bronchosp.  long-act ß  2-agon.is appropr. ie.pts not adeq.control.with inhal. corti-  on identic.dos.of compon.
       (S2) LINCTUS, A39/10.1/0390.  coster. & inhal.short-act.ß  2-agon.or pts.adeq. control. on both inhal.  (S4) HFA INHALER, A42/21.5.4/0218, 0219, 0220
       709817-001, 200 ml, R74,85    corticoster.& long-act.ß  2-agon.  715189-001: 25/50 µg, 120 dos., R150,69
       Dosage: Admin.3-4xdly. Do not exceed recomm. max.dos.  (S4) MET.DOS.INHAL, 42/21.5.1/0895  721412-001: 25/50 µg, (Synchrobreathe) 120 dos., R150,70
       Adults: 10 ml. Childr.6-12 yrs: 5 ml. 2-6 yrs:2,5-5 ml.  723841-001: 100/6 µg, 120 actuat., R300,00  715190-001: 25/125 µg, 120 dos., R202,53
       Contraindications: Card.arrhythm., tachycard., MAOI’s  Dosage: Bear in mind when tfd pts that due to the extra fine particle   721413-001: 25/125 µg, (Synchrobreathe) 120 dos., R202,54
       Side effects: Less freq: Musculoskelet.cramps, GI disturbs. Freq.  size tot.dly dos.should be low than a non extrafine formulat.& dos to   715191-001: 25/250 µg, 120 dos., R272,46
       unknown: Hypersens.reacts. incl. paradoxic.bronchosp./angioed./  be indiv. Dly use even when asymptomat.  721414-001: 25/250 µg, (Synchrobreathe) 120 dos., R272,45
       urticar./ hypotens. & collapse, hyperglycaem., lactic. acidos., hy-  Adults 18 yrs & old: 1-2 inhalat.2xdly. Max.dly. dos: 4 inhalat.  Dosage: Titr.to low.dos.effect.contr.sympt.
       pokalaem.potent.by corticoster./diuret./ xanthine & hypox., halluci-  Adults & adolesc.12 yrs.& old: 2 inhalat.of reqd. strength 2xdly.
       nat.in childr., hyperactiv. & restlessn., tachycard., palpitat., myocard.   Side effects: Pharyngit.,influenza, oral fung. infect., pharyng./oe-  Contraindications: Safety in pregn.& lactat.not est.
                                     sophag.& vag.candidias., gastroenterit., sinusit., granulocytopen.,
       ischaem., periph.vasodilat., hypotens., skelet. musc.fine trem.partic.  Side effects: Hypokalaem., headache, trem., palpitat., card.ar-
       of hands, headache, nerv. tens., trans.ser.aminotrans.rise, skin rash,   thrombocytopen., allerg.dermatit., hypersens., adren. suppress., hy-  rhythm., hypersens.reacts. incl. angioed., musc.cramp/-pain, ar-
                                     pokalaem., hyperglycaem., restlessn., abnorm.behav., sleep disord.,
       headache, dizzin., sweat.                                  thralg., oropharyng. candidias., vag.candidias., Cushing syndr./ fea-
       Warnings and special precautions: Hyperthyroid., myocard.in-  hallucinat., headache, trem., dizzin., glauc., cataract., otosalpingit.,   tures., adren.suppress., decr.bone min.density, psych. disords., CNS
       suffic., QT-interv. prolongat. susceptibil., hypertens., diab.mellit., sev.  palpitat., ECG QT correct.interv.prolong., ECG change, tachycard.,   effs., cataract, glauc., incr. IOP, conjunctivit., eye irrit., bronchit., nas.
       asthma monit.plasma K  conc.as hypokalaem. poss.which may be po-  tachydysrhythm., ventric.extrasystol., ang.pect., atrial fibrillat., hy-  congest. /-discharge, rhinit., sinusit., nasopharyngit., paradox. bron-
                 +
       tent.by hypox.& acidos./ other concom.meds.caus. hypokalaem./card.   peraem., flush., dysphon., rhinit., cough, product.cough, throat irrit.,   chosp., otit.media., dysphon., epistax., sneez., GI disturbs., hoarsen.,
       dysrhythm., high dos.incr.ser.S/E risk incl.card. dysrhythm., pept.ulc.  asthmat.cris., paradoxic.bronchosp., dyspn., asthma exacerbat., GI
       hist., sev.hepat./ren. impairm., safety in pregn.& lactat.not est., may   disturbs., burn.lip sensat., prurit., rash, hyperhidros., urticar., angioed.,   throat irrit., skin rash, ecchymos., contus., prurit., PID, dysmenorrh.,
       delay onset of labour, small amnts cross placenta  musc.spasm, myalg., growth retardat.in childr.& adolesc., nephrit.,   malaise, fatig., weight gain, vir.GI/ resp.infect., eosinophil., neuropa-
       Interactions: Incr.hypokalaem.risk.with sympathomimet./ diuret./  periph.oed., incr./decr.BP, decr.bone density, QTc interv.prolongat.  thy, keratit., chest pain, cough, rhinorrh., poss.syst.cortico-ster.effs.&
       corticoster./xanthines        Warnings and special precautions: Not for ac. asthma attack,   adrenocortic.suppress.
                                                                  Special precautions: Childr.may be more suscept. to infects.eg
                                                          rd
                                     pts.with ischaem.heart dis./ card.dysrrhythm.esp.3  degr.AV block &
       FLEMEZE, J&J                  tachydysrhythm., sev.heart dis.partic.ac.MI, idiopath.subvalvul.aortic   chickenpox/measles, avoid both non-select.& select. ß-block.unless
       Orciprenaline sulphate 5 mg, bromhexine HCl 4 mg/5 ml. Sugar   stenos./hypertroph. obstruct. cardiomyopathy/congest.HF/occlus.  there are compell.reasons, corticoster.teratogen.in animals, not for
       & alcoh.free.                 vasc. dis. partic.arterioscleros, arter.hypertens.& aneurysm, thyrotoxi-  ac.sympt.relief, progress./sudd.deteriorat.of asthma control, no abrupt
       Indications: Cough assoc.with bronchosp.& tenacious phlegm.  cos./ known or suspect. prolongat. of QT interv./diab.mellit./ phaeo-  withdr., discont.in case of paradoxic.bronchosp., transf.from other oral/
       (S2) BRONCHODILAT.SYRUP 29/10.1/0289.  chromocyt. & untreat.hypokalaem., monit. pts. at risk of hypokalaem.,   inhal. steroids, pts.wean.of oral steroids whose adrenocortic. funct.
       819743-003: 100 ml, R25,69    bld.gluc.monit.recomm. in diabet., do not admin.for at least 12 hrs.  is imp., rarely poss.unmask. underly.eosinophil.condits., monit.childr.
       819743-011: 200 ml, R51,41    bef. halogen.anaesth., act./quiesc.pulm.TB., fung./vir infects., abrupt   height.if treatm.prolong., medic./surg.emerg./elect.proced. /stress,
       Dosage: Admin.3xdly. Adults & childr.over 12 yrs: 10-20 ml. Chil-  discontin., reass.ther.if dos. requirem. incr.to maint.control, do not init.  treat.concur.infects., act./quiesc.pulmon. TB, thyrotoxicos.
       dr. 3-12 yrs: 5-10 ml. Und. 3 yrs: 2,5-5 ml. Do not exceed max.dos.  treatm.dur.an exacerbat./if asthma is worsen., discont. immed.& sub-  Drug interactions: Potent.incr.system.expos.to fluticasone with
       Contraindications: Hypersens.to sympath. amines, hypertroph.  sitit.altern.ther.in case of paradoxic. bronchosp., pts.to contin.treatm.  strong CYP 3A4 inhibit.
       obstruct. cardiomyopathy, tachyarrhythm., MAOI’s.  but seek medic.advic.if asthma sympts.remain uncontroll./ wors.aft.
       Side effects: CNS effs., CV sympts., hypotens., diffic. micturit./urin.  init., do not use as 1  treatm. for asthma, titrate dos to low.effect.  SERETIDE, GSK, [PWR]
                                             st
       retent., dyspn., cough, weakn., alt.gluc.metabol., hypersalivat., tightn.  dos.to reduc. risk of system.effs., consid.risk of adren.suppress. dur.  Salmeterol 50 µg, fluticasone propionate 100 µg, (250 µg &
       of chest., asthma exacerbat., irrit.of allerg.reacts., paradox. broncho-  periods of stress/elect.surg.when addit. system.corticoster.may be   500 µg)/blister
       constrict., hypokalaem., incr. card.risk with high dos.furth.aggrav.by   need., pts.transf.from system.act.corticoster., pt. to rinse mouth aft.   Indications: Reg.prophylact.treatm.of atop. asthma when stabilis.
       concom. use with meds. caus.hypokalaem.& card. dysrrhythm. or if   inhalat.to reduc.risk of dysphon. & oropharyng. candidias., poss.af-  on identic.dos.of compon., sev.COPD & hist of rep.exacerbat.with
       hypox.& acidos.pres., GI disturbs.  fect.pts.abilit to drive/use machin., not recomm.in pts.und.18 yrs.of   signific. sympts.despite reg.bronchodilat.ther.
       Special precautions: Hyperthyroid, CV dis., occlus. vasc.disord.,   age as no data avail.for use, contains small amount of ethanol, evid.of   (S4) ACCUHALER, 33/21.5.4/0413, 0414, 0415
       antihypertens.ther., ang. pain poss. precipit.in pts.with ang.pect.,   reproduct.toxic.aft.high system.expos., detect in milk of lactat.anim.,   874493-005: 50/100 µg, 60 blisters, R379,40
       pept. ulcerat., observe for dis.contr.decline, pref.to admin.as on-  no data avail.in hepat./ren.impairm., incr.risk of ventric. dysrrhythm.  874507-006: 50/250 µg, 60 blisters, R525,96
       demand treatm., insuffic.contr. diabet. mellit., clos.-angle glauc.,   with meds.known to prolong QTc-interv.  874515-009: 50/500 µg, 60 blisters, R700,02
       halogen. anaesthet.
       Drug interactions: Poss.addit.CV effs.with concom. sympathom-  Drug interactions: ß block.may reduc./abolish. eff. of formoterol.,   Dosage: Titr.to low.dos.effect.contr.sympt. Adults & childr.12
                                     ß-adrenerg.meds.potent.have addit.effs.with formoterol., quinidine/
       imet., incr.risk arrythm.with card. glycosid., quinidine/TCA’s.  yrs.&old: 1 inhalat.of reqd. strength 2xdly. Childr.4 yrs & old: 1 in-
                                     disopyramide/ procainamide/phenothiazines/ antihistamines/ MAOIs   halat. 50/100 ug strength 2xdly.
       FOXAIR, (Aspen Pharmacare) GSK, [PWR] &  and TCAs can prolong.QTc interv., L-dopa/L-thyroxine/oxytocin & alco-  Chron.obstruct.pulm.dis: Adults: 1 inhalat. 50/250 ug OR
       Salmeterol 50 µg, fluticasone propionate 100 µg, (250 µg &   hol an imp.card.tol.towards ß 2-sympathomimet., MAOI’s and agents   50/500 ug strength 2xdly.
       500 µg)/blister               with simil.propert.eg furazolidone & procarbazine may precipit.hyper-  (S4) CFC FREE INHALER, 35/21.5.4/0411,0412,0413
       Indications: Reg.prophylact.treatm.of atop. asthma when stabilis.  tens.reacts., elev. risk of dysrrhythm.with concom.halogenat. hydro-  Salmeterol 25 µg, fluticasone propionate 50 µg, (125 µg & 250 µg)/actuat.
       on identic.dos.of compon., chron. COPD incl.bronchit.& emphysema,   carbs anaesthes., xanthine derivat./steroids/ diuret.may potent.poss.  Indications: Reg.prophylact.treatm.of atop. asthma when stabilis.
       sev. COPD & hist of rep.exacerbat.with signific. sympts. despite reg.  hypokalaem.eff.of ß  2-agonists.  on identic.dos.of compon
       bronchodilat.ther.                                         894989-006: 25/50 µg, 120 actuat., R379,40
       (S4) ACCUHALER, 42/21.5.4/0581, 0582, 0583  RELVAR ELLIPTA, (Aspen Pharmacare) GSK &  894990-004: 25/125 µg, 120 actuat., R525,96
       715009-001: 50/100 µg, 60 blisters, R243,70  Fluticasone furoate 92(184)µg, vilanterol 22 (22)µg/ per inhalat.  895006-007: 25/250 µg, 120 actuat., R700,02
       715008-001: 50/250 µg, 60 blisters, R298,95  Indications: Maint./prevent.treatm.of asthma, maint. treatm.of   Dosage: Must be used regular.even when asymptomat. Titr.to low.
       715007-001: 50/500 µg, 60 blisters, R442,09  airflow obstruct.in COPD incl. chron. bronchit.&/emphys., reduc.ex-  dos.effect.contr.sympt.
       Dosage: Titr.to low.dos.effect.contr.sympt. Adolesc. 12 yrs.&   acerbat.of COPD in pts.with exacerbat.hist.  Adults & childr.12 yrs.&old: 2 inhalat.of requir. strength 2xdly.
       old: 1 inhalat.of reqd. strength 2xdly. Childr.4 yrs & old: 1 inhalat.   (S4) POWD.FOR INHALAT, 48/21.5.1/0249, 0250
       50/100 ug strength 2xdly.     723300-001: 92/22 µg, 30 blisters, R319,77  Contraindications: Safety in pregn.& lactat.not est.
                                                                  Side effects: Trem., headache, palpitat., musc. cramps, card.ar-
       Chron.obstruct.pulm.dis: Adults: 1 inhalat. 50/250 ug OR   723303-001: 184/22 µg, 30 blisters, R499,55
       50/500 ug strength 2xdly.     Dosage: For inhalat.only, admin.at same time every day, rinse   rhythm., arthralg., hypersens. reacts., hypokalaem., hoarsen., can-
       (S4) INHALER, 42/21.5.4/0244, 0245, 0246  mouth aft.inhalat.   didias., poss. syst.cortico-ster.effs.& adrenocortic.suppress.
       Salmeterol 25 µg, fluticasone propionate 50 µg, (125 µg & 250 µg)/  Asthma: Adults & childr.12 yrs.& old: 1 inhalat. of reqd. strength   Special precautions: Not for relief of ac. sympts., no abrupt with-
       actuat.                       1xdly., use reg.even when asymptomat., use inhal.short-act. ß 2-agon.  dr., discont.in case of paradoxic.bronchosp., transf.from other oral/
       Indications: Reg.prophylact.treatm.of atop. asthma when stabilis.  for immed. relief.if symts.arise.betw.dos.  inhal. steroids, progress./sudd.deteriorat.of asthma control, pts.
       on identic.dos.of compon.     COPD: Adults: 1 inhalat.of 92/22 µg formulat. once dly.  wean.of oral steroids whose adrenocortic. funct.is imp., rarely poss.
       715752-001: 25/50 µg, 120 actuat., R214,14  Contraindications: Sev.milk-prot.allergy, treatm. of ac.asthma   unmask.of underly.eosinophil.condits., monit.childr.height.if treatm.
       715753-001: 25/125 µg, 120 actuat., R287,80  sympts./ac.exacerbat.in COPD for which a short-act. bronchodilat.is   prolong., medic./surg.emerg./elect.proced. /stress, treat.concur.
       715754-001: 25/250 µg, 120 actuat., R387,16  reqd., safety in pregn./lactat./childr.&lt;12 yrs.not est.  infects., act./quiesc.pulmon. TB, thyrotoxicos., avoid both non-se-
       Dosage: Must be used regular.even when asymptomat. Titr.to low.  Side effects: Pneum., URTI, bronchit., influenza, mouth & throat   lect.& select. ß-block.unless there are compell.reasons, corticoster.
       dos.effect.contr.sympt.       candidias., headache, extrasystol., nasopharyngit., oropharyng.pain,   teratogen. in animals.
       Adults & childr.12 yrs.& old: 2 inhalat.of requir. strength 2xdly.  sinusit., pharyngit., abdom.pain, arthralg., back pain, fracts., pyrex.  Drug interactions: Poss.interact.with substrates /inhibit.of CYP 3A4</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page194.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page190.html">190</a>&nbsp;&nbsp;&nbsp;<a href="page191.html">191</a>&nbsp;&nbsp;&nbsp;<a href="page192.html">192</a>&nbsp;&nbsp;&nbsp;<a href="page193.html">193</a>&nbsp;&nbsp;&nbsp;<a href="page194.html">194</a>&nbsp;&nbsp;&nbsp;<a href="page195.html">195</a>&nbsp;&nbsp;&nbsp;<a href="page196.html">196</a>&nbsp;&nbsp;&nbsp;<a href="page197.html">197</a>&nbsp;&nbsp;&nbsp;<a href="page198.html">198</a>&nbsp;&nbsp;&nbsp;<a href="page199.html">199</a>&nbsp;&nbsp;&nbsp;<a href="page200.html">200</a>
             </td>
             <td width="35%"><a href="page196.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page196.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
